Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 07:32 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
IVF Versus Gonadotropin Therapy in Women With CC Resistant PCOS
NCT02458963 · Mohamed Sayed Abdelhafez · PHASE4 · withdrawn · last registry update 2017-05-10 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
No reason was published
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | The registry record gives no reason | – | Registry record, Mohamed Sayed Abdelhafez |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against LHCGR within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2018-04-06Results posted on the registry: Merck KGaA, Darmstadt, Germany, GONAL-f® (NCT01183143)
- 2018-03-30Results posted on the registry: Merck KGaA, Darmstadt, Germany, Gonal-f + Recombinant human chorionic gonadotrophin (r-hCG) (NCT00249834)
- 2018-03-27Results posted on the registry: Merck KGaA, Darmstadt, Germany, Recombinant human follicle stimulating hormone (r-hFSH) + Recombinant human luteinizing hormone (r-hLH) (NCT01110707)
- 2018-03-02Results posted on the registry: Ferring Pharmaceuticals, menotropin + recombinant FSH (NCT02554279)
- 2018-03-02Also stopped (terminated): Instituto de Investigacion Sanitaria La Fe, Bravelle (NCT02605070)
- 2018-02-23Results posted on the registry: Wake Forest University Health Sciences, clomiphene plus gonadotropins + Leuprolide flare (NCT01921166)
- 2018-02-22Phase 3 first posted: Eastern Virginia Medical School, Progesterone Vaginal Gel 8% + Letrozole Oral Tablet (NCT03440359)
- 2018-02-06Phase 3 first posted: National and Kapodistrian University of Athens, hCG + Placebo (NCT03423537)
- 2017-11-27Phase 3 first posted: Benha University, Triptorelin SR (NCT03353883)
- 2017-10-18Results posted on the registry: Fertility Biotech AG, AFOLIA + Gonal-f® RFF (NCT01687712)
- 2017-10-17Results posted on the registry: University of California, San Diego, recombinant human chorionic gonadotropin + Recombinant human follicle stimulating hormone (NCT00989781)
- 2017-09-25Results posted on the registry: UConn Health, hCG + hCG (NCT01815138)
- 2017-05-04Phase 3 first posted: Assiut University, Gonadotropin-Releasing Hormone Analogue + Gonadotropin releasing hormone antagonist (NCT03139474)
- 2017-03-06Phase 3 first posted: Changchun GeneScience Pharmaceutical Co., Ltd., Triptorelin for Injection + Recombinant Human Choriogonadotropin alfa Solution for Injection (NCT03071172)
- 2017-01-24Results posted on the registry: Merck KGaA, Darmstadt, Germany, Pergoveris® + GONAL-f® (NCT02047227)
- 2017-01-12Phase 3 first posted: Organon and Co, Corifollitropin alfa + hCG (NCT03019575)
- 2016-12-16Also stopped (withdrawn): Weill Medical College of Cornell University, Low-dose Clomiphene + High dose gonadotropins (NCT01577199)
- 2016-11-01Results posted on the registry: Michigan State University, human chorionic gonadotropin (hCG) + Placebo Comparator (for hCG) (NCT01786252)
- 2016-09-27Phase 3 first posted: Assiut University, Recombinant Human Chorionic Gonadotrophin + human chorionic gonadotrophin + gonadotrophin releasing hormone agonist (NCT02916173)
- 2016-09-23Phase 3 first posted: The University of Hong Kong, Letrozole (NCT02912988)
- 2016-09-23Also stopped (terminated): Northwest Center for Infertility and Reproductive Endocrinology, Menopur 150 international units + Endometrin 100 mg (NCT02510534)
- 2016-08-11Results posted on the registry: Merck KGaA, Darmstadt, Germany, Gonal-f® (NCT01871532)
- 2016-08-11Also stopped (terminated): Merck KGaA, Darmstadt, Germany, Gonal-f® (NCT01871532)
- 2016-08-11Phase 3 first posted: Tel-Aviv Sourasky Medical Center, hCG (Ovitrelle 250 mcg mcg - Merck Serono) + hCG (Ovitrelle 250 mcg mcg - Merck Serono) + GnRH agonist (Decapeptyl 0.2mg - Ferring Gmgh) (NCT02862782)
- 2016-07-07Phase 3 first posted: Royan Institute, Intra uterine injection of tissue culture medium containing HCG+ET + Intra uterine injection of tissue culture medium +ET (NCT02825108)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision